CIBC Asset Management’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-3,868
Closed -$226K 1545
2021
Q4
$226K Buy
3,868
+99
+3% +$5.78K ﹤0.01% 1299
2021
Q3
$223K Buy
3,769
+537
+17% +$31.8K ﹤0.01% 1272
2021
Q2
$281K Hold
3,232
﹤0.01% 1038
2021
Q1
$266K Buy
3,232
+77
+2% +$6.34K ﹤0.01% 1022
2020
Q4
$287K Buy
+3,155
New +$287K ﹤0.01% 923